The Use of Direct Oral Anticoagulants (DOACs) in Cirrhosis

Please join us for our next Pharmacy Resident Seminar presentation on Friday, November 11, 2022, presented by UIC College of Pharmacy PGY1 Pharmacy Practice Resident, Rachel Christensen, PharmD.

Type of Activity: Knowledge-based                                    Target Audience: Pharmacists

Time: Friday, November 11, 2022,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2022-2023
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)
Meeting ID: 871 4292 0130
Passcode: 25699265

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Describe the pathophysiology of increased thrombosis risk and increased bleeding risk in patients with cirrhosis
• Summarize current evidence of the use of DOACs in patients with cirrhosis for common indications including atrial fibrillation (AF) and portal venous thrombosis (PVT)
• Explain safety concerns and monitoring parameters associated with DOAC therapy in patients with cirrhosis

Disclosure: The speaker, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose. Mentor, Dr. Heinrich has no relevant financial conflicts of interest to disclose in relation to this activity.